Trial · NCT02583698
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mortality in both groups | 28 days | |
| Secondary | Number of patients with development or progression of esophageal varices in both groups. | 3 Months | |
| Secondary | Number of patients with reduction in hepatic venous pressure gradient (HVPG) in both groups. | 3 Months | |
| Secondary | Number of patients with regression in esophageal varices in both groups. | 3 Months | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 28 days | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 60 days | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 3 months | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 28 days | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 2 months | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 3 Months | |
| Secondary | Number of patients who will develop esophageal variceal bleeding in both groups | 28 days | |
| Secondary | Number of patients who will develop esophageal variceal bleeding in both groups | 2 Months | |
| Secondary | Number of patients who will develop esophageal variceal bleeding in both groups | 3 Months | |
| Secondary | Development of complications in both groups | 28 days | AKI,Pneumonia,SBP and other infections |
| Secondary | Development of complications in both groups | 2 months | AKI,Pneumonia,SBP and other infections |
| Secondary | Development of complications in both groups | 3 months | AKI,Pneumonia,SBP and other infections |
| Secondary | Mortality in both groups | 2 months | |
| Secondary | Mortality in both groups | 3 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02583698/registered